// App-Quantinova.ai

1783 : Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Researchers

Presenter

  • Angela C. Weyand

Principal Investigators

  • Kenneth D Friedman

  • Sweta Gupta

  • Kristina M. Haley

  • Chunla He

  • Salley Pels

  • Jonathan C. Roberts

  • Crystal Watson

  • Robert F. Sidonio Jr

Medical Centers

  • University of Michigan, Ann Arbor, MI

  • Blood Research Institute, Milwaukee, WI.

  • Indiana Hemophilia & Thrombosis Center, Indianapolis, IN

  • Hemophilia Treatment Center, Oregon Health and Science University, Portland, OR

  • American Thrombosis and Hemostasis Network, Rochester, NY

  • Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI

  • The Medical College of Wisconsin Inc., Peoria, IL

  • American Thrombosis and Hemostasis Network, Rochester, NY

  • Emory University, Aflac Cancer and Blood Disorders, ATLANTA, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • American Thrombosis And Hemostasis Network (ATHN)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved